The weekly litigation news digest is live. Subscribe now

IP Verse

Taiho Pharmaceutical competitive analysis

Latest patents of Taiho Pharmaceutical opposed by its competitors

Explore Taiho Pharmaceutical's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jan 1, 2026
Patent NumberPublication DateTitleTotal Oppositions

Get instant alerts of patent oppositions faced by Taiho Pharmaceutical

EP2815753
Nov 5, 2025Oral Pharmaceutical Composition1
EP1849470
Mar 20, 2024Anticancer Drug Containing Alpha, Alpha, Alphatrifluorothymidine And Thymidine Phosphorylase Inhibitor2
EP3042669
Mar 8, 2023Antitumor Agent And Antitumor Effect Enhancer2
EP3012255
Oct 13, 2021Stabilized Crystal Of Tipiracil Hydrochloride, And Crystallization Method For Same1
EP2815752
May 20, 2020Oral Pharmaceutical Composition1

Latest PTAB cases involving Taiho Pharmaceutical

Discover the latest PTAB cases involving Taiho Pharmaceutical, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Taiho Pharmaceutical with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jan 1, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
TAIHO PHARMACEUTICAL - 7 - -
GENERICS UK214 - - -
STADA ARZNEIMITTEL11028 - -
TEVA PHARMACEUTICALS210161712